No role for pre-operative CRT in the treatment of operable Gastric cancer – ESMO

ESMO shared on LinkedIn:

“Final results presented at ESMO24 from the phase III TOPGEAR trial show that the addition of pre-operative chemoradiotherapy (CRT) to peri-operative chemotherapy improved pathological outcomes but not long-term OS in patients with resectable Gastric Cancer and Gastro-oesophageal Cancer.

For Elizabeth Smyth, the findings confirm that there is no role for pre-operative CRT in the treatment of operable Gastric cancer. CRT appeared to effectively target the local tumour, but did not address distant metastases, which remain the primary cause of mortality.

Read the full news on the ESMO Daily Reporter.”

Source: ESMO/LinkedIn

More posts featuring ESMO24 on oncodaily.com